
Oscar Health (OSCR) Stock Forecast & Price Target
Oscar Health (OSCR) Analyst Ratings
Bulls say
Oscar Health is well positioned by its improving underwriting profile, with 3Q26 risk adjustment payable guidance revised to (17.5%) from (20.0%) at the midpoint and MLR improved to 81.0%, signaling better-than-expected claims dynamics and a path toward roughly 80% MLR over time. Management also raised 2026 expectations for Earnings from Operations to $600 million to $800 million while keeping revenue at $18.7 billion to $19.0 billion and SG&A at 15.6% to 16.1%, showing operating leverage even amid ACA volatility. Longer term, the thesis is supported by projected ACA individual market growth to ~23 million lives by 2029, over 20% revenue CAGR from 2026-2029, and $4.0B-$4.5B of targeted cumulative internal capital generation.
Bears say
Oscar Health is priced for a 14.0% weighted average rate increase in CY27, but that pricing appears to assume a flat Individual ACA market at 17.0M only briefly before normal contraction to 13.9M-15.4M by Dec-27, pressuring the company to gain share merely to keep membership flat. The firm may benefit from competitor exits and its tech-forward managed care platform, yet the analyst remains cautious because the ACA risk pool could worsen as program integrity controls, metal-tier mix shifts, and post-subsidy behavior complicate the true level of sustainable enrollment. With expected CY26 membership of 2.5M and an implied need to reach 17.3% market share to offset a smaller market, the outlook remains negative on uncertainty around morbidity and medical loss ratio adequacy.
This aggregate rating is based on analysts' research of Oscar Health and is not a guaranteed prediction by Public.com or investment advice.
Oscar Health (OSCR) Analyst Forecast & Price Prediction
Start investing in Oscar Health (OSCR)
Order type
Buy in
Order amount
Est. shares
0 shares
FAQs About Oscar Health (OSCR) Forecast
Oscar Health (OSCR) Analyst Forecast & Price Prediction
Start investing in Oscar Health (OSCR)
Order type
Buy in
Order amount
Est. shares
0 shares